{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:21:52Z","timestamp":1787772112888,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Metformin toxicity is a life-threatening condition with high morbidity and mortality. Toxicity predominantly occurs in the setting of acute renal dysfunction, as the drug is solely eliminated by the kidneys. While this risk is widely known to clinicians, diagnosing metformin toxicity is challenging because commercially available serum metformin levels require days to weeks to result. Therefore, the intensivist must rely on medical history, clinical presentation, and routine laboratory findings to make the preliminary diagnosis. Treatment of metformin toxicity includes supportive fluid hydration, vasopressors, and emergent hemodialysis (HD). We report three critically ill patients who had near-fatal severe metformin-induced lactic acidosis. Their metformin levels were markedly higher than the toxicity threshold reported by the Federal Drug Agency. These patients made a prompt and complete recovery after the initiation of HD. We also review the pathophysiology, clinical presentation, diagnosis, and treatment of metformin toxicity.<\/jats:p>","DOI":"10.4103\/ijciis.ijciis_46_23","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:52:49Z","timestamp":1711533169000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Metformin toxicity in the intensive care unit: A case series and review of the literature"],"prefix":"10.4103","volume":"14","author":[{"given":"Katherine Nicole","family":"Peake","sequence":"first","affiliation":[{"name":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Tessier","sequence":"additional","affiliation":[{"name":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Longo","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Luke\u2019s University Health Network, Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Stahlnecker","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, St. Luke\u2019s University Health Network, Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamudiamen","family":"Idahosa","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, St. Luke\u2019s University Health Network, Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zanders","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, St. Luke\u2019s University Health Network, Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Ido","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, St. Luke\u2019s University Health Network, Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40261-019-00799-0","article-title":"Emerging trends in metformin prescribing in the United States from 2000 to 2015","volume":"39","author":"Le","year":"2019","journal-title":"Clin Drug Investig"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"},{"key":"R3-20240902","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr Rev"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","article-title":"The UK Prospective Diabetes Study (UKPDS):Clinical and therapeutic implications for type 2 diabetes","volume":"48","author":"King","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The multicenter metformin study group","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/j.1552-4604.1995.tb04033.x","article-title":"Kidney function and age are both predictors of pharmacokinetics of metformin","volume":"35","author":"Sambol","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2337\/dc09-1284","article-title":"Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function:Clinical recommendations","volume":"33","author":"Frid","year":"2010","journal-title":"Diabetes Care"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/dc05-0338","article-title":"Metformin-induced pancreatitis:A possible adverse drug effect during acute renal failure","volume":"29","author":"Fimognari","year":"2006","journal-title":"Diabetes Care"},{"key":"R10-20240902","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1542-4758.2012.00698.x","article-title":"Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis","volume":"17","author":"Kang","year":"2013","journal-title":"Hemodial Int"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/pmj.76.892.125","article-title":"Haemolytic anaemia due to metformin","volume":"76","author":"Kashyap","year":"2000","journal-title":"Postgrad Med J"},{"key":"R12-20240902","first-page":"030","article-title":"The side effects of metformin \u2013A review","volume":"6","author":"Ghosal","year":"2019","journal-title":"J Diabetes Metab Disord"},{"key":"R13-20240902","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/IJGM.S49657","article-title":"Metformin-induced mixed hepatocellular and cholestatic hepatic injury:Case report and literature review","volume":"6","author":"Saadi","year":"2013","journal-title":"Int J Gen Med"},{"key":"R14-20240902","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4239\/wjd.v13.i8.654","article-title":"Metformin toxicity:A meta-summary of case reports","volume":"13","author":"Juneja","year":"2022","journal-title":"World J Diabetes"},{"key":"R16-20240902","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5414\/CP202686","article-title":"Hemodialysis-refractory metformin-associated lactate acidosis with hypoglycemia, hypothermia, and bradycardia in a diabetic patient with belated diagnosis and chronic kidney disease","volume":"55","author":"Zibar","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R17-20240902","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12882-018-0875-8","article-title":"Metformin associated lactic acidosis:A case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up","volume":"19","author":"Angioi","year":"2018","journal-title":"BMC Nephrol"},{"key":"R18-20240902","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/15563650.2013.784774","article-title":"Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs","volume":"51","author":"Al Abri","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"R19-20240902","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/CCM.0b013e3181a02490","article-title":"Metformin-associated lactic acidosis:A prognostic and therapeutic study","volume":"37","author":"Seidowsky","year":"2009","journal-title":"Crit Care Med"},{"key":"R20-20240902","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc7137","article-title":"Metformin-associated lactic acidosis in an intensive care unit","volume":"12","author":"Peters","year":"2008","journal-title":"Crit Care"},{"key":"R22-20240902","doi-asserted-by":"crossref","first-page":"e01561","DOI":"10.1213\/XAA.0000000000001561","article-title":"Achieving high dialysis dose via continuous renal replacement therapy in the setting of metformin associated lactic acidosis:A case series","volume":"16","author":"Reynolds","year":"2022","journal-title":"A A Pract"},{"key":"R23-20240902","first-page":"191","article-title":"Metformin-Associated Lactic Acidosis (MALA):Clinical profile and outcomes in patients admitted to the intensive care unit","volume":"12","author":"Biradar","year":"2010","journal-title":"Crit Care Resusc"},{"key":"R24-20240902","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin","volume":"338","author":"Misbin","year":"1998","journal-title":"N Engl J Med"},{"key":"R25-20240902","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxrep.2021.12.010","article-title":"Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO","volume":"9","author":"Ives Tallman","year":"2022","journal-title":"Toxicol Rep"},{"key":"R26-20240902","doi-asserted-by":"crossref","first-page":"e0273678","DOI":"10.1371\/journal.pone.0273678","article-title":"Metformin-associated lactic acidosis and factors associated with 30-day mortality","volume":"17","author":"Thammavaranucupt","year":"2022","journal-title":"PLoS One"},{"key":"R27-20240902","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2337\/diabetes.55.02.06.db05-1064","article-title":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase","volume":"55","author":"Davis","year":"2006","journal-title":"Diabetes"},{"key":"R28-20240902","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3949\/ccjm.82a.14098","article-title":"Lactic acidosis:Clinical implications and management strategies","volume":"82","author":"Reddy","year":"2015","journal-title":"Cleve Clin J Med"},{"key":"R29-20240902","doi-asserted-by":"crossref","first-page":"113726","DOI":"10.1016\/j.ejmech.2021.113726","article-title":"Biguanides drugs:Past success stories and promising future for drug discovery","volume":"224","author":"Grytsai","year":"2021","journal-title":"Eur J Med Chem"},{"key":"R30-20240902","first-page":"e4739","article-title":"Metformin use and metformin-associated lactic acidosis in intensive care unit patients with diabetes","volume":"11","author":"Rajasurya","year":"2019","journal-title":"Cureus"},{"key":"R31-20240902","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","volume":"88","author":"Andersen","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"R32-20240902","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcrc.2011.07.071","article-title":"Prevalence and significance of lactic acidosis in diabetic ketoacidosis","volume":"27","author":"Cox","year":"2012","journal-title":"J Crit Care"},{"key":"R33-20240902","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.kint.2019.08.023","article-title":"L-lactic acidosis:Pathophysiology, classification, and causes;emphasis on biochemical and metabolic basis","volume":"97","author":"Kamel","year":"2020","journal-title":"Kidney Int"},{"key":"R34-20240902","first-page":"31","article-title":"Metformin-induced lactic acidosis with emphasis on the anion gap","volume":"28","author":"Blough","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R35-20240902","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/15563650.2019.1686514","article-title":"Time to development of metformin-associated lactic acidosis","volume":"58","author":"Theobald","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R36-20240902","doi-asserted-by":"crossref","first-page":"e23200","DOI":"10.1371\/journal.pone.0023200","article-title":"Management of metformin-associated lactic acidosis by continuous renal replacement therapy","volume":"6","author":"Keller","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"R37-20240902","first-page":"S68","article-title":"Metformin intoxication requiring dialysis","volume":"15","author":"Nguyen","year":"2011","journal-title":"Hemodial Int"},{"key":"R38-20240902","first-page":"3868051","article-title":"Severe metformin poisoning successfully treated with simultaneous venovenous hemofiltration and prolonged intermittent hemodialysis","volume":"2018","author":"Leonaviciute","year":"2018","journal-title":"Case Rep Crit Care"},{"key":"R39-20240902","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning:Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup","volume":"43","author":"Calello","year":"2015","journal-title":"Crit Care Med"},{"key":"R40-20240902","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2165\/11536790-000000000-00000","article-title":"Lactic acidosis induced by metformin:Incidence, management and prevention","volume":"33","author":"Lalau","year":"2010","journal-title":"Drug Saf"},{"key":"R41-20240902","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s11096-020-01069-2","article-title":"Identifying patients with metformin associated lactic acidosis in the emergency department","volume":"42","author":"van Berlo van de Laar","year":"2020","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_46_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:30Z","timestamp":1787769030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_46_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijciis.ijciis_46_23","relation":{},"ISSN":["2229-5151","2231-5004"],"issn-type":[{"value":"2229-5151","type":"print"},{"value":"2231-5004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}